Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Clark

Showing results (291-300 of 305) with videos related to

Pageof 31
Sort By:
Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Plasmatic HIV-1 soluble gp120 is associated with immune dysfunction and inflammation in ART-treated individuals with undetectable viremiaMehdi Benlarbi, Jonathan Richard, Catherine Bourassa, et al.
The Journal of Infectious Diseases|November 30, 2023
Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable ViremiaMehdi Benlarbi, Jonathan Richard, Catherine Bourassa, et al.
AIDS (London, England)|May 31, 2024
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIVLeanne McCabe, James E Burns, Arash Latifoltojar, et al.
Circulation. Heart Failure|May 21, 2019
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart FailureJoão Pedro Ferreira, Job Verdonschot, Timothy Collier, et al.
British Journal of Haematology|April 5, 2024
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMTFrancesco Onida, Luuk Gras, Junran Ge, et al.
American Journal of Hematology|February 22, 2024
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMTNicola Polverelli, Edouard F Bonneville, Liesbeth C de Wreede, et al.
Bone Marrow Transplantation|June 3, 2025
Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMTKatia Perruccio, Katherine N Ward, Gloria Tridello, et al.
Nature Biotechnology|December 18, 2018
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identificationBrendan Bulik-Sullivan, Jennifer Busby, Christine D Palmer, et al.
Bone Marrow Transplantation|February 24, 2025
Tuberculosis after hematopoietic cell transplantation: retrospective study on behalf of the Infectious Diseases Working Party of the EBMTJoanna Drozd-Sokołowska, Gloria Tridello, Inge Verheggen, et al.
Elife|July 13, 2021
Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 worldJaspreet Toor, Susy Echeverria-Londono, Xiang Li, et al.
Pageof 31

Showing results (291-300 of 305) with videos related to

Sort By:
Pageof 31
Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Plasmatic HIV-1 soluble gp120 is associated with immune dysfunction and inflammation in ART-treated individuals with undetectable viremiaMehdi Benlarbi, Jonathan Richard, Catherine Bourassa, et al.
The Journal of Infectious Diseases|November 30, 2023
Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable ViremiaMehdi Benlarbi, Jonathan Richard, Catherine Bourassa, et al.
AIDS (London, England)|May 31, 2024
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIVLeanne McCabe, James E Burns, Arash Latifoltojar, et al.
Circulation. Heart Failure|May 21, 2019
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart FailureJoão Pedro Ferreira, Job Verdonschot, Timothy Collier, et al.
British Journal of Haematology|April 5, 2024
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMTFrancesco Onida, Luuk Gras, Junran Ge, et al.
American Journal of Hematology|February 22, 2024
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMTNicola Polverelli, Edouard F Bonneville, Liesbeth C de Wreede, et al.
Bone Marrow Transplantation|June 3, 2025
Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMTKatia Perruccio, Katherine N Ward, Gloria Tridello, et al.
Nature Biotechnology|December 18, 2018
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identificationBrendan Bulik-Sullivan, Jennifer Busby, Christine D Palmer, et al.
Bone Marrow Transplantation|February 24, 2025
Tuberculosis after hematopoietic cell transplantation: retrospective study on behalf of the Infectious Diseases Working Party of the EBMTJoanna Drozd-Sokołowska, Gloria Tridello, Inge Verheggen, et al.
Elife|July 13, 2021
Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 worldJaspreet Toor, Susy Echeverria-Londono, Xiang Li, et al.
Pageof 31